Pluri Inc. APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition
Pluri Inc. (PLUR) reported APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition of $1.40 million for the 9-month period ending 2013-03-31, per its 10-Q filed 2014-05-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition · last filed 2014-05-08
- 2013-03-31: APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 9 month $1.40M.
| Period end | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 9 month |
|---|---|
| 2013-03-31 | $1.40M 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |